Urologic Diseases  >>  Thymoglobulin (anti-thymocyte globulin (rabbit))  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
NCT00407160: A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients

Completed
N/A
21
US
The University of Texas Medical Branch, Galveston
Kidney Diseases
01/11
01/11
NCT00859131: Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

Completed
N/A
200
US
Rabbit Antithymocyte globulin, Thymoglobulin, Daclizumab, daclizumab, zenapax
Medical University of South Carolina, Genzyme, a Sanofi Company
End Stage Renal Disease
07/12
07/14

Download Options